Plain-English translation of NCT05194982 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called to treat advanced cancers that have spread or cannot be surgically removed. Researchers want to find the safest and most effective dose of this treatment, and to understand how your body processes it and how well it works against your cancer.
Many patients with advanced solid tumors have limited or no standard treatment options available. This trial aims to develop a new treatment option by carefully testing this medication to determine whether it is safe enough and effective enough to help patients with these difficult-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as an intravenous infusion starting with a 3-week first cycle. If the treatment is helping your cancer and you are tolerating it well, you may continue to receive additional cycles. Your doctors will monitor you closely for side effects and measure your tumor response using imaging scans. Treatment will stop if your cancer gets worse, you experience side effects that are too severe, or for other medical reasons.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
China